Global Pharmaceutical Quality Control Testing Market Growth (Status and Outlook) 2025-2031

The global Pharmaceutical Quality Control Testing market size is predicted to grow from US$ 11420 million in 2025 to US$ 17290 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.

Quality control (QC) testing of pharmaceuticals must be rigorous and involves multiple techniques including GC/MS, LC/MS, and elemental analysis techniques.QC verifies that ingredients and products meet written and approved standards, often called “specifications”. The QC laboratory tests samples of raw materials and finished products. It is critical to get accurate results from QC tests.

The global pharmaceutical quality control testing market refers to the market for testing and analyzing pharmaceutical products to ensure their quality, safety, and efficacy. Quality control testing is an essential process in the pharmaceutical industry to comply with regulatory requirements and maintain high standards of product quality.

Key factors driving the growth of the global pharmaceutical quality control testing market include:

Increasing regulatory standards: Regulatory authorities, such as the FDA in the United States and the EMA in Europe, impose stringent regulations on pharmaceutical manufacturers to ensure the safety and efficacy of drugs. This drives the demand for quality control testing to comply with regulatory standards and demonstrate the quality and safety of pharmaceutical products.

Growth in the pharmaceutical industry: The pharmaceutical industry is continuously expanding, driven by factors such as the increasing prevalence of chronic diseases, an aging population, and advancements in drug development. As the industry grows, the need for quality control testing also increases to maintain high-quality products and prevent any risks to patient health.

Rising emphasis on product quality and safety: With increasing awareness among consumers and healthcare professionals, there is a growing emphasis on product quality and safety. Pharmaceutical companies are focusing on quality control testing to ensure that their products meet the required standards, minimizing the risk of contamination, adulteration, or other quality issues.

Technological advancements in testing methods: The development of advanced testing methods and technologies, such as chromatography, spectroscopy, mass spectrometry, and molecular biology techniques, has significantly improved the efficiency and accuracy of pharmaceutical quality control testing. These advancements drive the adoption of such testing methods in the industry.

Outsourcing of quality control testing services: Many pharmaceutical companies are outsourcing their quality control testing to specialized contract testing organizations. Outsourcing allows companies to access specialized expertise, reduce costs, and focus on their core competencies, thereby driving the growth of the outsourcing segment in the pharmaceutical quality control testing market.

In conclusion, the global pharmaceutical quality control testing market is driven by increasing regulatory standards, the growth of the pharmaceutical industry, the focus on product quality and safety, advancements in testing methods, and the outsourcing of quality control testing services. As the pharmaceutical industry continues to grow and regulatory requirements become more stringent, the demand for quality control testing is expected to increase in the coming years.

LPI (LP Information)' newest research report, the “Pharmaceutical Quality Control Testing Industry Forecast” looks at past sales and reviews total world Pharmaceutical Quality Control Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Quality Control Testing sales for 2025 through 2031. With Pharmaceutical Quality Control Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Quality Control Testing industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Quality Control Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Quality Control Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Quality Control Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Quality Control Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Quality Control Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Quality Control Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Sterility Testing
Bioburden Testing
Endotoxin Testing
Stability Testing
Extractable & Leachable Testing
Raw Material Testing
Others

Segmentation by Application:
Vaccines
Plasma Product
Drugs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioMerieux SA
SGS S.A.
Charles River Laboratories International Inc.
WiXi AppTec
Merck KGaA
Thermo Fisher Scientific Inc.
Toxikon Corporation
Sartorius AG
REMI Group
Perkin Elmer
Agilent Technologies Inc
Waters Corporation
Charles River Laboratories International Inc
Catalent, Inc
Eurofins Scientific SE

Please note: The report will take approximately 2 business days to prepare and deliver.